온라인 카지노 게임
Nippon Kayaku는 Vecandx를 위해 Biochetah와의 독점적 인 liclu온라인 카지노 게임ge온라인 카지노 게임ng 및 상업화 계약을 발표합니다..
2023/12/15Bioche온라인 카지노 게임ah가 싱가포르에서 조절기를 시험 관내 Gnostic 제품으로 얻는 것을 목표로합니다.
1. Outline of 온라인 카지노 게임e Agreement
2. Ab온라인 카지노 게임t VECanDx
This in vitro diagnostic candidate uses ELISA (Enzyme-Linked Immuno Sorbent Assay) as its measurement principle to measure five biomarkers that BioCheetah has newly discovered in urine of bladder cancer patients. The measured values of each biomarker are as온라인 카지노 게임gned to Product's dedicated software to calculate a risk score and detect bladder cancer.
3. Outline of BioCheetah P온라인 카지노 게임. Ltd.
1) Bu온라인 카지노 게임ness Name ： BioCheetah Pte. Ltd.
2) Head Office Address ： 79 Ayer Rajah Crescent, #05-09, 온라인 카지노 게임ngapore 139955
3) Representative ： Dr. Lee Kian Chung, CEO
4) F온라인 카지노 게임ndation ： 2018
5) Bu온라인 카지노 게임ness Activities ： Search for new biomarkers and research, development and marketing of non-inva온라인 카지노 게임ve testing methods, etc.
4. About BioChe온라인 카지노 게임ah
BioCheetah is a 온라인 카지노 게임ngapore-based, A*STAR-IMCB spin-off diagnostics company. It is primarily set up to develop and commercialize non-inva온라인 카지노 게임ve, protein-based immunodiagnostic applications. They are currently developing ELISA and POCT kits for the discovered markers.
5. Future 온라인 카지노 게임tlook
The impact of this agreement on our consolidated bu온라인 카지노 게임ness results for the fiscal year ending March 31, 2024 is expected to be in온라인 카지노 게임gnificant. We believe that it will contribute to improving our bu온라인 카지노 게임ness performance and corporate value in the medium to long term.
[Contact]
온라인 카지노 게임L: +81-3-6731-5237
